Colorectal Cancer Molecular Diagnostics Global Market Opportunities And Strategies To 2034

Description

Colorectal cancer molecular diagnostics refers to a category of diagnostic technologies and tools designed to detect specific molecular alterations associated with colorectal cancer. These alterations include gene mutations, microsatellite instability and DNA (Deoxyribonucleic Acid) methylation patterns, which are critical for understanding disease behavior and informing clinical decisions. These diagnostics play a central role in enhancing the accuracy of screening, confirming diagnoses, guiding treatment strategies and monitoring for disease progression or recurrence.

The global colorectal cancer molecular diagnostics market reached a value of nearly $2,560.91 million in 2024, having grown at a compound annual growth rate (CAGR) of 6.54% since 2019. The market is expected to grow from $2,560.91 million in 2024 to $3,827.29 million in 2029 at a rate of 8.37%. The market is then expected to grow at a CAGR of 7.85% from 2029 and reach $5,585.53 million in 2034.

Shift Towards Personalized Medicine

During the historic period, the colorectal cancer molecular diagnostics market mainly driven by a shift towards personalized medicine. The move away from one-size-fits-all treatment strategies toward tailored diagnostic and therapeutic approaches based on patient-specific genetic, molecular and biomarker profiles enhanced precision and outcomes in colorectal cancer (CRC) care. Personalized medicine enables better matching of targeted therapies, reduction in adverse effects and more efficient use of resources. For instance, in October 2022, according to the Personalized Medicine Coalition, a US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system, estimated that more than 75,000 genetic testing products and 300 personalized medicines are on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Therefore, the shift towards personal medicine drove the growth of the colorectal cancer molecular diagnostics market.

Growing Adoption Of At-Home Colorectal Cancer Screening Kits

Major players in the colorectal cancer molecular diagnostics market are focusing on the launch and expansion of at-home screening kits designed to improve convenience and encourage greater participation in regular cancer screening programs. These initiatives are aimed at reducing barriers such as clinic visits and invasive procedures, while also expanding access to underserved populations. For instance, in March 2024, Guardant Health, a US-based precision oncology company, launched Shield, its first blood-based colorectal cancer screening test available for at-home use. Shield enables individuals to collect samples outside clinical settings, thereby improving compliance and broadening adoption. By emphasizing patient-centered accessibility, Guardant Health aims to increase early cancer detection rates and strengthen its position in the non-invasive diagnostics market.

The global colorectal cancer molecular diagnostics market is concentrated, with large players operating the market. The top ten competitors in the market made up to 49.36% of the total market in 2024.

Colorectal Cancer Molecular Diagnostics Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global colorectal cancer molecular diagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for colorectal cancer molecular diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The colorectal cancer molecular diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider colorectal cancer molecular diagnostics market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics: - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by technology and by end users.
Key Trends: - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Analysis:- Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Global Market Size And Growth: - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis: - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation: - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by technology and by end users in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size And Growth: - Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape: - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies:- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking: - Briefs on the financials comparison between major players in the market.
Competitive Dashboard: - Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions: - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Recent Developments:- Information on recent developments in the market covered in the report.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for colorectal cancer molecular diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups
Appendix:- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Type: Instruments; Reagents And Kits; Services
2) By Technology: Polymerase Chain Reaction (PCR); Sequencing; Mass Spectrometry; Transcription Mediated Amplification; Chips And Microarrays; Isothermal Nucleic Acid Amplification Technology (INAAT); In Situ Hybridization (FISH/ISH); Immunohistochemistry (IHC)
3) By End Users: Hospitals; Ambulatory Surgical Centers; Diagnostic Laboratories; Homecare Settings; Other End Users
Companies Mentioned: F-Hoffmann-La Roche; Exact Sciences Corporation; Illumina Inc; Qiagen N.V.; Guardant Health
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; colorectal cancer molecular diagnostics indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1819

1 Executive Summary

1.1 Colorectal Cancer Molecular Diagnostics - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Colorectal Cancer Molecular Diagnostics Market Definition And Segmentations
6.4 Market Segmentation By Type
- 6.4.1 Instruments
- 6.4.2 Reagents And Kits
- 6.4.3 Services
6.5 Market Segmentation By Technology
- 6.5.1 Polymerase Chain Reaction (PCR)
- 6.5.2 Sequencing
- 6.5.3 Mass Spectrometry
- 6.5.4 Transcription Mediated Amplification
- 6.5.5 Chips And Microarrays
- 6.5.6 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 6.5.7 In Situ Hybridization (FISH/ISH)
- 6.5.8 Immunohistochemistry (IHC)
6.6 Market Segmentation By End Users
- 6.6.1 Hospitals
- 6.6.2 Ambulatory Surgical Centers
- 6.6.3 Diagnostic Laboratories
- 6.6.4 Homecare Settings
- 6.6.5 Other End Users

7 Major Market Trends

7.1 Expansion Of Blood-Based Colorectal Cancer Screening Tests
7.2 Growing Adoption Of At-Home Colorectal Cancer Screening Kits
7.3 Adoption Of Fully Automated PCR Platforms For Colorectal Cancer Testing

8 Global Colorectal Cancer Molecular Diagnostics Growth Analysis And Strategic Analysis Framework

8.1 Global Colorectal Cancer Molecular Diagnostics PESTEL Analysis
- 8.1.1 Political
- 8.1.2 Economic
- 8.1.3 Social
- 8.1.4 Technological
- 8.1.5 Environmental
- 8.1.6 Legal
8.2 Analysis Of End Use Industries
- 8.2.1 Hospitals
- 8.2.2 Ambulatory Surgical Centers
- 8.2.3 Diagnostic Laboratories
- 8.2.4 Homecare Settings
- 8.2.5 Other End-Users
8.3 Global Colorectal Cancer Molecular Diagnostics Market Growth Rate Analysis
8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
- 8.4.1 Market Drivers 2019 - 2024
- 8.4.2 Market Restraints 2019 - 2024
8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
8.6 Forecast Growth Contributors/Factors
- 8.6.1 Quantitative Growth Contributors
- 8.6.2 Drivers
- 8.6.3 Restraints
8.7 Global Colorectal Cancer Molecular Diagnostics Total Addressable Market (TAM)

9 Global Colorectal Cancer Molecular Diagnostics Market Segmentation

9.1 Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.2 Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.3 Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.4 Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.5 Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.6 Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Colorectal Cancer Molecular Diagnostics Market, Regional and Country Analysis

10.1 Global Colorectal Cancer Molecular Diagnostics Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.2 Global Colorectal Cancer Molecular Diagnostics Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

11.1 Summary
11.2 Market Overview
- 11.2.1 Region Information
- 11.2.2 Market Information
- 11.2.3 Background Information
- 11.2.4 Government Initiatives
- 11.2.5 Regulations
- 11.2.6 Regulatory Bodies
- 11.2.7 Major Associations
- 11.2.8 Taxes Levied
- 11.2.9 Corporate Tax Structure
- 11.2.10 Investments
- 11.2.11 Major Companies
11.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.6 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
- 11.9.1 Country Information
- 11.9.2 Market Information
- 11.9.3 Background Information
- 11.9.4 Government Initiatives
- 11.9.5 Regulations
- 11.9.6 Regulatory Bodies
- 11.9.7 Major Associations
- 11.9.8 Taxes Levied
- 11.9.9 Corporate Tax Structure
- 11.9.10 Investments
- 11.9.11 Major Companies
11.10 China Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.11 China Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.12 China Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.13 India Market
11.14 India Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.15 India Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.16 India Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
- 11.19.1 Country Information
- 11.19.2 Market Information
- 11.19.3 Background Information
- 11.19.4 Government Initiatives
- 11.19.5 Regulations
- 11.19.6 Regulatory Bodies
- 11.19.7 Major Associations
- 11.19.8 Taxes Levied
- 11.19.9 Corporate Tax Structure
- 11.19.10 Major Companies
11.20 Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.22 Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.23 Australia Market
11.24 Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.25 Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.26 Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.27 Indonesia Market
11.28 Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.29 Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.30 Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.31 South Korea Market
11.32 Summary
11.33 Market Overview
- 11.33.1 Country Information
- 11.33.2 Market Information
- 11.33.3 Background Information
- 11.33.4 Government Initiatives
- 11.33.5 Regulations
- 11.33.6 Regulatory Bodies
- 11.33.7 Major Associations
- 11.33.8 Taxes Levied
- 11.33.9 Corporate Tax Structure
- 11.33.10 Major Companies
11.34 South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.35 South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.36 South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

12.1 Summary
12.2 Market Overview
- 12.2.1 Region Information
- 12.2.2 Market Information
- 12.2.3 Background Information
- 12.2.4 Government Initiatives
- 12.2.5 Regulations
- 12.2.6 Regulatory Bodies
- 12.2.7 Major Associations
- 12.2.8 Taxes Levied
- 12.2.9 Corporate Tax Structure
- 12.2.10 Investments
- 12.2.11 Major Companies
12.3 Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.6 Western Europe Colorectal Cancer Molecular Diagnostics Market: Country Analysis
12.7 UK Market
12.8 UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.9 UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.10 UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.11 Germany Market
12.12 Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.14 Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.15 France Market
12.16 France Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.17 France Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.18 France Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.19 Italy Market
12.20 Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.22 Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.23 Spain Market
12.24 Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.26 Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

13.1 Summary
13.2 Market Overview
- 13.2.1 Region Information
- 13.2.2 Market Information
- 13.2.3 Background Information
- 13.2.4 Government Initiatives
- 13.2.5 Regulations
- 13.2.6 Regulatory Bodies
- 13.2.7 Major Associations
- 13.2.8 Taxes Levied
- 13.2.9 Corporate Tax Structure
- 13.2.10 Major companies
13.3 Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.6 Eastern Europe Colorectal Cancer Molecular Diagnostics Market: Country Analysis
13.7 Russia Market
13.8 Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.10 Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

14.1 Summary
14.2 Market Overview
- 14.2.1 Region Information
- 14.2.2 Market Information
- 14.2.3 Background Information
- 14.2.4 Government Initiatives
- 14.2.5 Regulations
- 14.2.6 Regulatory Bodies
- 14.2.7 Major Associations
- 14.2.8 Taxes Levied
- 14.2.9 Corporate Tax Structure
- 14.2.10 Investments
- 14.2.11 Major Companies
14.3 North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.6 North America Colorectal Cancer Molecular Diagnostics Market: Country Analysis
14.7 USA Market
14.8 Summary
14.9 Market Overview
- 14.9.1 Country Information
- 14.9.2 Market Information
- 14.9.3 Background Information
- 14.9.4 Government Initiatives
- 14.9.5 Regulations
- 14.9.6 Regulatory Bodies
- 14.9.7 Major Associations
- 14.9.8 Taxes Levied
- 14.9.9 Corporate Tax Structure
- 14.9.10 Investments
- 14.9.11 Major Companies
14.10 USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.11 USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.12 USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.13 Canada Market
14.14 Summary
14.15 Market Overview
- 14.15.1 Country Information
- 14.15.2 Market Information
- 14.15.3 Background Information
- 14.15.4 Government Initiatives
- 14.15.5 Regulations
- 14.15.6 Regulatory Bodies
- 14.15.7 Major Associations
- 14.15.8 Taxes Levied
- 14.15.9 Corporate Tax Structure
- 14.15.10 Major Companies
14.16 Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.17 Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.18 Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

15.1 Summary
15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulations
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Investments
- 15.2.11 Major Companies
15.3 South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.4 South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.5 South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.6 South America Colorectal Cancer Molecular Diagnostics Market: Country Analysis
15.7 Brazil Market
15.8 Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.10 Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

16.1 Summary
16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Investments
- 16.2.11 Major Companies
16.3 Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

17.1 Summary
17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Major Companies
17.3 Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.4 Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.5 Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

18.1 Company Profiles
18.2 F. Hoffman-La Roche Ltd
- 18.2.1 Company Overview
- 18.2.2 Products And Services
- 18.2.3 Business Strategy
- 18.2.4 Financial Overview
18.3 Exact Sciences Corporation
- 18.3.1 Company Overview
- 18.3.2 Products And Services
- 18.3.3 Business Strategy
- 18.3.4 Financial Overview
18.4 Illumina Inc
- 18.4.1 Company Overview
- 18.4.2 Products And Services
- 18.4.3 Business Strategy
- 18.4.4 Financial Overview
18.5 Qiagen N.V.
- 18.5.1 Company Overview
- 18.5.2 Products And Services
- 18.5.3 Business Strategy
- 18.5.4 Financial Overview
18.6 Guardant Health Inc
- 18.6.1 Company Overview
- 18.6.2 Products And Services
- 18.6.3 Business Strategy
- 18.6.4 Financial Overview

19 Other Major And Innovative Companies

19.1 Thermo Fisher Scientific
- 19.1.1 Company Overview
- 19.1.2 Products and Services
19.2 Danaher Corporation
- 19.2.1 Company Overview
- 19.2.2 Products and Services
19.3 Hologic Inc.
- 19.3.1 Company Overview
- 19.3.2 Products and Services
19.4 Agilent Technologies
- 19.4.1 Company Overview
- 19.4.2 Products and Services
19.5 Quest Diagnostics Incorporated
- 19.5.1 Company Overview
- 19.5.2 Products and Services
19.6 Siemens Healthineers
- 19.6.1 Company Overview
- 19.6.2 Products and Services
19.7 Biomerieux SA
- 19.7.1 Company Overview
- 19.7.2 Products and Services
19.8 Grifols S.A.
- 19.8.1 Company Overview
- 19.8.2 Products and Services
19.9 Sysmex Corporation
- 19.9.1 Company Overview
- 19.9.2 Products and Services
19.10 Abbott Laboratories
- 19.10.1 Company Overview
- 19.10.2 Products and Services
19.11 Labcorp Holdings Inc.
- 19.11.1 Company Overview
- 19.11.2 Products and Services
19.12 Strand Life Sciences
- 19.12.1 Company Overview
- 19.12.2 Products and Services
19.13 Geneoscopy
- 19.13.1 Company Overview
- 19.13.2 Products and Services
19.14 Karkinos Healthcare
- 19.14.1 Company Overview
- 19.14.2 Products and Services
19.15 Novigenix
- 19.15.1 Company Overview
- 19.15.2 Products and Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

22.1 New Day Diagnostics LLC Acquired Assets Of Epigenomics AG
22.2 New Day Diagnostics LLC Merged With EDP Biotech Corporation

23 Recent Developments In Colorectal Cancer Molecular Diagnostics

23.1 Development Of Molecular Residual Disease (MRD) Tests For Colorectal Cancer Monitoring
23.2 Launch Of Next-Generation Colorectal Cancer Screening Test

24 Opportunities And Strategies

24.1 Global Colorectal Cancer Molecular Diagnostics Market In 2029 - Countries Offering Most New Opportunities
24.2 Global Colorectal Cancer Molecular Diagnostics Market In 2029 - Segments Offering Most New Opportunities
24.3 Global Colorectal Cancer Molecular Diagnostics Market In 2029 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies

25 Colorectal Cancer Molecular Diagnostics Market, Conclusions And Recommendations

25.1 Conclusions
25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People

26 Appendix

26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer